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James J. Kochkodan1, Jun Ding2, Rajan P. Nair1, Abhishek Aphale1, John J. Voorhees1 and James T. Elder1,3
The Wnt gene family encodes a set of highly conserved secreted signaling proteins that have major roles in
embryogenesis and tissue homeostasis. Yet the expression of this family of important mediators in psoriasis, a
disease characterized by marked changes in keratinocyte growth and differentiation, is incompletely
understood. We subjected 58 paired biopsies from lesional and uninvolved psoriatic skin and 64 biopsies
from normal skin to global gene expression profiling. WNT5A transcripts were upregulated fivefold in lesional
skin, accompanied by increased Wnt-5a protein levels. Notably, WNT5A mRNA was markedly induced by IL-1a,
tumor necrosis factor-a, IFN-g, and transforming growth factor-a in cultured keratinocytes. Frizzled 2 (FZD2) and
FZD5, which encode receptors for Wnt5A, were also increased in lesional psoriatic skin. In contrast, expression
of WIF1 mRNA, encoding a secreted antagonist of the Wnt proteins, was downregulated 410-fold in lesional
skin, along with decreased WNT inhibitory factor (WIF)-1 immunostaining. Interestingly, pathway analysis along
with reduced AXIN2 expression and lack of nuclear translocation of b-catenin indicated a suppression of
canonical Wnt signaling in lesional skin. The results of our study suggest a shift away from canonical Wnt
signaling toward noncanonical pathways driven by interactions between Wnt-5a and its cognate receptors in
psoriasis, accompanied by impaired homeostatic inhibition of Wnt signaling by WIF-1 and dickkopf.
Journal of Investigative Dermatology (2010) 130, 1849–1859; doi:10.1038/jid.2010.67; published online 8 April 2010
INTRODUCTION
The Wnt family of signaling proteins are highly conserved,
lipid-modified, secreted molecules that participate in multi-
ple developmental events during embryogenesis (Logan and
Nusse, 2004). The Wnt proteins have also been shown to
have fundamental roles in controlling cell proliferation,
cell-fate determination, and differentiation during adult
homeostasis (van Amerongen et al., 2008). Classically, Wnt
signaling has been divided into two major pathways. First, the
canonical signaling pathway involves the use of Frizzled (Fz)
receptors paired with low-density lipoprotein receptor-
related proteins (LRPs) 5 and 6 as co-receptors (Wehrli
et al., 2000). This leads to the activation and nuclear
translocation of b-catenin and is typically linked to cell-fate
determination and stem cell maintenance. Alternatively, Wnt
signaling occurs through the noncanonical pathway invol-
ving Fz receptors, independent of the b-catenin activation
cascade (Kuhl et al., 2000). In mammals 19 Wnt proteins and
10 Fz transmembrane receptors are known (van Amerongen
et al., 2008). To date, several noncanonical pathways have
been described, involving the receptor tyrosine kinase Ror2
(Oishi et al., 2003), the atypical tyrosine kinase Ryk (Lu et al.,
2004), and Wnt-Ca2þ signaling pathways (Kohn and Moon,
2005), all signaling modes associated with controlling cell
adhesion and movement. On the basis of this concept, Wnt
proteins have been divided into two main categories depend-
ing on which pathway they activate (Sen and Ghosh, 2008).
Wnt-1, Wnt-3A, and Wnt-8 have been classified as canonical
Wnts whereas others such as Wnt-5a and Wnt-11 have been
classified as noncanonical Wnts (van Amerongen et al., 2008).
However, it has recently become evident that this is probably
an oversimplification, as typical noncanonical Wnt ligands
such as Wnt-5a (Liu et al., 2005) and Wnt-11 (Tao et al., 2005)
have been shown to be able to activate b-catenin signaling.
Thus, it is likely that individual Wnt proteins may activate
multiple pathways, depending on which Fz receptors are
expressed on the cell surface (van Amerongen et al., 2008).
Three families of secreted proteins are known to inhibit Wnt
signaling activity. These are the secreted Frizzled-related protein
family that bind Wnt proteins and prevent them from binding to
the Fz receptors (Kawano and Kypta, 2003); the Dickkopf (Dkk)
protein family that promote the internalization of LRP making it
unavailable for Wnt binding (Logan and Nusse, 2004); and
finally WNT inhibitory factor (WIF)-1, a secreted protein that
binds to Wnt proteins and inhibits their activity (Hsieh et al.,
1999). As is evident from the description above, this combina-
tion of multiple ligands along with multiple receptors and
soluble inhibitors creates an extremely complex system.
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Psoriasis is a disease characterized by chronic inflamma-
tion and altered differentiation and hyperproliferation of
keratinocytes. In normal skin the fraction of proliferating
keratinocytes is probably around 20% (Wright and
Camplejohn, 1983), whereas in psoriasis it is almost 100%,
and the mean cell cycle time is reduced from 13 days to
36 hours (Weinstein et al., 1985). Moreover, it has been
suggested that this hyperproliferation is not restricted to the
basal epidermal layer containing keratinocyte stem cells, but
may also involve suprabasal cells (Leigh et al., 1985). Despite
the fundamental functions of Wnt proteins in controlling cell
proliferation and differentiation, surprisingly little is known
about the state of Wnt signaling in psoriasis. Of the Wnt
proteins, only Wnt-5a has been described to be upregulated
in lesional psoriatic skin as determined by gene expression
(Reischl et al., 2007) and was recently shown to synergize
with type 1 IFNs (Romanowska et al., 2009). However, the
pathogenic role of this molecule in psoriasis is presently
unknown. The aims of this study were to determine the
cellular source of the increased expression of Wnt-5a in
psoriasis and to characterize the expression of other
mediators of canonical versus noncanonical Wnt signaling.
RESULTS
Differential Expression of Wnt Pathway Genes in Psoriasis
Lesions
We have previously used a microarray data set to explore the
differences between normal skin and uninvolved psoriatic
(Gudjonsson et al., 2009b) skin, to assess the expression of
candidate risk genes in psoriasis (Nair et al., 2009) and the
activity of the sonic hedgehog pathway in psoriasis
(Gudjonsson et al., 2009a). Here we show that this data set
contains a differential expression of Wnt pathway genes in
psoriatic lesions. Global gene expression analysis revealed
significant changes in several members of the Wnt ligand
family and several of the Fz receptors in lesional psoriatic
skin compared with both normal and uninvolved psoriatic
skin (Figure 1). Of the Wnt ligands, WNT5A showed a 5.0-
fold upregulation (Po0.0001) and WNT10A had a 1.3-fold
upregulation (Po0.0001). In contrast, WNT2, WNT2B,
WNT5B, and WNT7B were all downregulated (1.3-, 1.3-,
1.2-, and 1.3-fold, respectively, all P ’so0.0001; Table 1). Of
the Fz receptor genes, Frizzled 2 (FZD2) and FZD5, which
encode receptors for Wnt-5a, had a 1.2- and 1.3-fold
upregulation, respectively (Po0.0001), whereas FZD1,
FZD4, FZD7, FZD8, and FZD10 were decreased (1.3-, 1.5-,
1.7-, 1.4-, and 1.5-fold, respectively, all P ’so0.0001;
Table 1). The Fz homologues act in concert with the low-
density lipoprotein receptor-related proteins LRP5 or LRP6.
LRP6 demonstrated a 1.6-fold downregulation and data for
LRP5 was inconclusive due to a limited probe set.
Among the soluble inhibitors and modulators of Wnt
signaling, WIF1 was most strongly decreased in psoriatic
skin, being expressed at 14-fold less than in uninvolved skin
(Po0.0001). The secreted frizzled-related protein transcripts
SFRP1, SFRP2, SFRP4 and SFRP5 were all downregulated
(1.3-, 1.3-, 1.3- and 1.1-fold, respectively, Po0.001). In
addition, the Dkk homologue genes DKK1, DKK2, and DKK3
were downregulated by 1.6-, 2.2-, and 1.3-fold, respectively
(Po0.0001), whereas DKK4 showed a modest 1.2-fold
upregulation (Po0.0001).
Downstream members of the Wnt-canonical pathway,
such as b-catenin 1 (CTNNB1) and b-catenin-interacting
protein 1 (CTNNB1) were downregulated by 1.5- and 1.9-
fold, respectively (Po0.0001). Consistent with previously
published studies (Belso et al., 2008), cyclin D1 (CCND1),
which is downstream of b-catenin (Prasad et al., 2007), was
downregulated (2.0-fold, Po0.0001), whereas CCND2 was
upregulated (1.5-fold, Po0.0001).
Confirmation of Microarray Data by QRT-PCR
To validate the microarray results, we performed quantitative
real-time PCR (QRT)-PCR for several Wnt-related genes
including WIF1, WNT5A, DKK2, and CCND1, along with
keratin 16 (KRT16) as a positive control for upregulation in
lesional psoriatic skin (Leigh et al., 1995). This analysis
confirmed the upregulation of WNT5A (2.9-fold, Po0.001)
and downregulation of WIF1 (9.3-fold, Po0.05), DKK2
(8.4-fold, Po0.001), and CCND1 (4.3-fold, Po0.001). As
anticipated, KRT16 showed more than 40-fold upregulation
(Po0.001; Figure 2).
Wnt Canonical Pathway is Suppressed in Lesional Skin
To determine the effect of gene expression changes in
lesional psoriatic skin on the Wnt pathway, we used the
Ingenuity Pathway Analysis software tool (www.ingenuity.
com). Gene expression differences between normal control
skin and lesional psoriatic skin were overlaid onto a global
molecular network within the Ingenuity Pathway Knowledge
Base. This revealed global downregulation of nearly all
members of the canonical signaling pathway in psoriasis
(Figure 3a). Decreased activity of the canonical Wnt pathway
was confirmed by QRT-PCR for AXIN2 (Po0.05), a marker of
canonical Wnt signaling (Jho et al., 2002; Figure 3b).
Consistent with these results, we found b-catenin to be
decreased in lesional psoriatic skin (Figure 3c) and there was
decreased nuclear localization of b-catenin in psoriatic skin
compared to normal or uninvolved skin (insets in Figure 3c).
Wnt-5a is Upregulated in Lesional Skin Whereas WIF-1 is
Downregulated
We examined the protein levels of Wnt-5a and WIF-1
proteins in normal, psoriatic, and symptom-free skin from
psoriatic patients by semiquantitative immunohistochemical
analysis. Lesional psoriatic skin showed increased Wnt-5a
staining in both the epidermis and dermis compared with
control and uninvolved skin (Figure 4a). These findings were
confirmed using computer-assisted image quantification
(Figure 4c). There were strong foci of Wnt-5a staining in the
papillary dermis of lesional skin. Counterstaining with CD34
and CD31 did not show any colocalization (data not shown)
indicating that the source of this staining is not from vascular
structures. In addition, tissue lysates from normal, unin-
volved, and lesional psoriatic skin showed increased levels of
Wnt-5a protein in lesional psoriatic skin (Figure 4b). In
agreement with our gene chip and QRT-PCR data, we
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observed decreased WIF-1 staining in the epidermis of
lesional psoriatic skin, although, interestingly, there was a
slight increase in the dermis (Figure 4a and c). There was
slight nuclear staining of WIF-1 in epidermis of lesional skin
(Figure 4a) but similar nuclear staining has been seen in
bladder cancer (Urakami et al., 2006) but not in renal cell
carcinoma (Kawakami et al., 2009). The significance of this
nuclear staining in the psoriatic epidermis is at this time
not clear.
WNT5A Expression by Keratinocytes is Induced by Several
Proinflammatory Cytokines
Psoriatic skin is replete with proinflammatory cytokines and
growth factors. To examine the effects of such a cytokine
environment on Wnt expression by keratinocytes, we
stimulated normal human keratinocytes (NHKs) with tumor
necrosis factor (TNF)-a, IL-17A, IFN-g, IL-22, transforming
growth factor (TGF)-a and IL-1a or a combination of TGF-a
and IL-1a for 24 hours. WIF1 expression was undetectable in
both proliferating and differentiated NHKs (data not shown),
whereas WNT5A mRNA was readily detectable in both
(Figure 5). We observed an approximately 1.5- to 2-fold
increase in WNT5A expression treated with TGF-a, TNF-a,
IFN-g, or IL-1a. The combination of both TGF-a and IL-1a
had an additive effect resulting in a 2- to 3-fold increase in
WNT5A expression (Figure 5). There was no change in
WNT5A expression with IL-22 and IL-17A stimulation.
Interestingly, the effects of these cytokines were observed
only in the more differentiated keratinocytes, suggestive of a
role for differentiation in the development of cytokine
responsiveness. Baseline expression of WNT5A in both
proliferating and differentiated NHKs was comparable to that
of control and uninvolved skin. However, the maximum
induction of WNT5A expression observed after cytokine or
TGF-a stimulation was only about half the level of that
observed in lesional psoriatic skin (data not shown),
indicating that other additional mediators, or cell types, are
involved in WNT5A mRNA induction in lesional psoriatic
skin in vivo.
Effect of Exogenous Wnt-5a and WIF-1 on Keratinocytes
We were unable to observe any effect of recombinant Wnt-5a
and Wnt-3a on NHK growth or migration (data not shown).
As recombinant Wnt proteins lack posttranslational modifica-
tions that are essential for their full activity, we used secreted
Wnt-5a from a tranfected cell line to assess the effects of Wnt
agonists and antagonists on keratinocyte growth and function.
NHKs were cultured in the presence of diluted (20%, v/v)
conditioned medium from Wnt-5a-transfected cell line and a
control cell line in the presence of WIF-1 and anti-Wnt-5a
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Figure 1. Microarray analysis reveals that WNT5A is strikingly upregulated, and WIF1 downregulated, in the majority of lesional skin samples. This gene
expression heat map image used transcripts from 58 paired lesional and uninvolved psoriasis and 64 normal skin samples and shows Wnt pathway members,
regulators of Wnt signaling, and regulators of growth, proliferation, and transcription. In addition, genes involved in protein kinase activity, protein
phosphatases, protein ubiquitination, and other genes related to Wnt signaling are shown. Color key: red, increased expression; blue, decreased expression; as
indicated in the color key and histogram (inset).
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antibodies for 24, 48, 72, and 96 hours and counted at each
time point. Exogenous Wnt-5a had an suppressive effect on
keratinocyte growth (Po0.01, Figure 6a), which was
prevented by anti-Wnt-5a antibodies. There was a minimal
to no effect of WIF-1 on the antiproliferative effect of Wnt-5a
(Figure 6a and b). These data were confirmed by flow
cytometry using Carboxyfluorescein diacetate succinimidyl
ester-labeled NHK examined after 96 hours of culture
(Figure 6b).
DISCUSSION
Psoriasis is a common chronic inflammatory skin disease
characterized by marked changes in keratinocytes growth
and differentiation. The basis of this alteration in epidermal
growth and differentiation is incompletely understood but has
been shown to be dependent on the activity of the immune
infiltrate within the psoriatic lesions (Valdimarsson et al.,
1995). Several cytokines and growth factors have been
implicated in this process based on mouse models (Gudjons-
son et al., 2007) and in vitro/ex vivo studies. These include
cytokines and growth factors such as interleukin (IL)-1a (Lee
et al., 1997), vascular endothelial growth factor (Detmar
et al., 1994), the epidermal growth factors TGF-a (Elder et al.,
1989), amphiregulin (Cook et al., 1992), HB-EGF (Stoll and
Elder, 1998), and several cytokines secreted by the Th17
subset of T lymphocytes, most prominently IL-17 and IL-22
(Zaba et al., 2007). As outlined earlier, the Wnt family of
signaling proteins are a set of highly conserved molecules
that participate and control processes such as cell prolifera-
tion, cell-fate determination, and differentiation during adult
homeostasis (van Amerongen et al., 2008). The changes that
are observed in lesional psoriatic skin have been noted to
have many similarities to wound healing (Mansbridge et al.,
1984; Hertle et al., 1992), which is of interest as wounding
has been shown to activate the Wnt-mediated signaling
pathway (Ito et al., 2007). Thus, based on the functions of
these signaling proteins and the marked changes that occur
within psoriatic lesions, it would not be unanticipated that
these proteins may are important in the pathogenesis of
psoriasis.
To date, very few studies have been performed to
determine whether and how the Wnt pathway is activated
in psoriasis. One of the reasons for this is the complexity of
this signaling pathway. To date, 19 Wnt proteins and 10 Fz
transmembrane receptors have been described (van
Amerongen et al., 2008) that require the LRP5 and LRP6
co-receptors for effective signaling (Wehrli et al., 2000).
Classically, Wnt signaling has been divided into the
canonical pathway that leads to activation and nuclear
translocation of membrane-bound b-catenin and the non-
canonical pathway that is independent of b-catenin (Logan
and Nusse, 2004) but can be mediated by several different
signaling cascades (Logan and Nusse, 2004; Katoh, 2007). To
complicate matters, it is found that several of the Wnt
proteins, including Wnt-5a, can activate either pathway
depending on receptor context on the surface of the
responding cells (van Amerongen et al., 2008). Wnt-5a is
typically classified as a noncanonical Wnt as its transcrip-
tional activation has been reported to be b-catenin indepen-
dent (Sen and Ghosh, 2008). However, Wnt-5a has been
shown to be able to either activate or inhibit b-catenin
signaling depending on receptor context (Mikels and Nusse,
2006). The activity of the Wnt canonical pathway in
psoriasis, as determined by b-catenin activation, has been
controversial. A recently published study showed increased
nuclear b-catenin staining high in the suprabasal layer in
lesional psoriatic skin (Hampton et al., 2007) whereas
another study showed only membranous staining in lesional
psoriatic skin (Yamazaki et al., 2001), indicating lack of
b-catenin activation in lesional psoriatic skin. Thus, based on
these two reports it is not clear whether b-catenin activity is
increased in lesional psoriatic skin.
Table 1. Fold changes between lesional psoriatic (PP)
and control (NN) skin for Wnt family members and Fz
receptors present on the HU133 PLUS 2.0 microarray
Gene
Fold change
PP vs. NN P-value (FDR) Probe ID
WNT1 1.03 NS 208570_at
WNT2 0.74 2.54E23 205648_at
WNT2B 0.77 2.86E20 206458_s_at
WNT3 1.08 NS 221455_s_at
WNT4 1.01 NS 208606_s_at
WNT5A 5.01 3.19E176 205990_s_at
WNT5B 0.82 7.75E08 221029_s_at
WNT6 1.05 NS 221609_s_at
WNT7A 1.11 9.94E05 210248_at
WNT7B 0.774 2.80E15 217681_at
WNT8A 1.00 NS 224259_at
WNT8B 1.04 NS 207612_at
WNT9A 0.94 NS 230643_at
WNT9B 1.03 NS 1552973_at
WNT10A 1.31 4.69E17 223709_s_at
WNT11 0.92 NS 206737_at
WNT16 0.96 NS 221113_s_at
FZD1 0.74 1.50E14 204451_at
FZD2 1.16 4.41E06 210220_at
FZD3 0.95 NS 219683_at
FZD4 0.66 1.66E19 218665_at
FZD5 1.27 4.13E14 206136_at
FZD6 1.04 NS 203987_at
FZD7 0.58 5.19E26 203705_s_at
FZD8 0.66 3.86E29 227405_s_at
FZD9 1.07 NS 207639_at
FZD10 0.68 9.17E17 219764_at
Abbreviations: FDR, false discovery rate; NS, not significant.
P-value is corrected for multiple testing.
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To date only two studies have tried to directly address
whether the Wnt pathway was involved in the pathogenesis
of psoriasis (Reischl et al., 2007; Romanowska et al., 2009).
One of these studies was based on microarray gene
expression in 16 patients screening for 22,283 oligonucleo-
tide probes (Reischl et al., 2007). The authors determined that
10% of the differentially expressed genes in their study were
directly or indirectly related to the canonical Wnt/b-catenin
or to the noncanonical Wnt/Ca2þ pathways. Of these genes,
WNT5A was the one most markedly changed, being fivefold
upregulated compared with uninvolved psoriatic skin
whereas DKK2, an inhibitor of Wnt signaling, was found to
be downregulated (Reischl et al., 2007). On the basis of
decreased expression of cyclin D1 (CCND1), the authors
argued that this indicated decreased activity of the canonical
Wnt/b-catenin pathway (Reischl et al., 2007). Our study,
which is based on a microarray interrogating a much larger
probe set (455,000) and on a larger cohort (64 cases and 58
controls) has extended our knowledge on the status of the
Wnt family in psoriasis. We have been able to confirm the
findings of Reischl et al. (2007) on the upregulation of
WNT5A and downregulation of DKK2 and several of the Fz
receptors. Furthermore, we have been able to extend these
findings and show that several members of the b-catenin
pathway, including b-catenin itself, are downregulated in
lesional skin. Thus, there was both decreased expression of
the b-catenin gene and protein in lesional skin (Figure 3). In
addition there was decrease in nuclear translocation of b-
catenin in psoriatic skin compared with normal and unin-
volved skin (Figure 3c). These findings are consistent with the
decreased AXIN2 expression observed in lesional psoriatic
skin (Figure 3b), but AXIN2 is a reliable marker for canonical
pathway activation (Jho et al., 2002), and show that the
activity of the canonical Wnt pathway is suppressed in
lesional skin. As most, if not all, of the Wnt inhibitory genes
are downregulated in lesional psoriatic skin, including WIF1,
an interesting question is why the canonical Wnt pathway is
still depressed. Of all the Wnt family members, WNT5A was
highly upregulated, WNT10A and WNT7A expression were
moderately increased, and other Wnt members were either
unchanged or showed decreased expression (Table 1).
Importantly all the Fz receptors were downregulated except
FZD5, and FZD2, both of which have been shown not only to
be involved in non-canonical Wnt signaling (Slusarski et al.,
1997; Ahumada et al., 2002) but also to interact with Wnt-5a
(He et al., 1997; Slusarski et al., 1997). Thus, this pattern of
gene expression in lesional psoriatic skin is consistent with a
shift away from the canonical pathway toward the non-
canonical signaling mediated by Wnt-5a and its cognate
receptors.
The pathogenic role of Wnt-5a in psoriasis, if any, is still
unclear. Our study data suggest that the main source of Wnt-
5a in psoriatic lesions is the epidermis (Figure 4). Wnt-5a has
been implicated both in inflammatory responses of human
mononuclear cells (Blumenthal et al., 2006) and vascular
proliferation (Masckauchan et al., 2006), processes that have
been implicated in psoriasis pathogenesis (Lowes et al.,
2007). Vascular changes in psoriasis are characterized by
capillary elongation, widening, and tortuosity predominantly
in the dermal papillae (Hern and Mortimer, 2007). WNT5A
has been described to be expressed by human endothelial
cells and inhibit the canonical Wnt signaling (Masckauchan
et al., 2006). In addition, Wnt-5a has been shown to promote
angiogenesis (Masckauchan et al., 2006) and proliferation of
endothelial cells in a dose-dependent manner (Cheng et al.,
2008). Wnt-5a can induce expression of a number of genes
including Tie-2 (Masckauchan et al., 2006), which is a
receptor tyrosine kinase and functions as the receptor for
angiopoietins 1 and 2 (Kuroda et al., 2001). Tie-2 has been
shown to be upregulated in psoriasis (Kuroda et al., 2001)
and transgenic mouse model overexpressing Tie-2 in the skin
results in a psoriasis-like phenotype (Voskas et al., 2005). It is
well known that vascular changes reflected by redness of
lesions take a longer time to resolve than the thickness and
scaling. Given these data, it is enticing to speculate given the
lack of normalization of Wnt-5a during anti-TNF treatment
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Figure 2. Quantitative real-time PCR confirmed the altered expression of several components of the Wnt signaling pathways in psoriasis. Keratin 16 (KRT16)
expression was used as a positive control for lesional psoriasis skin. Data are expressed as fold change relative to normal skin. Bars indicate mean±SD (n¼ 10).
Statistical significance denoted: *Po0.05, **Po0.01, and ***Po0.001.
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Figure 3. Pathway analysis reveals global downregulation of nearly all members of the canonical Wnt signaling pathway in psoriasis. Global gene
expression differences between normal and lesional psoriatic skin were overlaid onto a global molecular and pathway network within the Ingenuity
Pathway Knowledge Base (a). This revealed near-global downregulation (green) of nearly all members of the canonical signaling pathway. However, several
genes associated with the noncanonical Wnt pathway were upregulated (pink), includingWNT5A and FZD5. Decreased activity of the canonical Wnt pathway
was confirmed by quantitative real-time PCR for AXIN2, a marker of canonical Wnt signaling (b). Bars indicate mean±SD, *Po0.05. Immunofluorescent
microscopy of normal, uninvolved, and psoriatic skin (scale bar¼ 100mm) (c) (original magnification,  20, n¼ 3).
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(unpublished observation) that Wnt-5a may have a role
in promoting and/or maintaining vascular changes in
lesional skin.
WNT5A has also been shown to be expressed by human
antigen-presenting cells through stimulation through Toll-like
receptors and directly by TNF-a (Blumenthal et al., 2006). In
this context, it is of interest that we observed increased
expression of Wnt-5a in lesional dermis although less than
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that seen for the epidermis (Figure 4). However, we did not
determine whether it was the inflammatory infiltrate or the
vascular cells that were the main source of dermal Wnt-5a in
psoriasis. TNF-a is a proinflammatory cytokine that has been
shown to have a central role in psoriasis (Gottlieb et al.,
2005) and treatments directed against TNF-a are highly
effective (Leonardi et al., 2003; Chew et al., 2004). As
mentioned above and confirmed in our study, TNF-a has
been shown to be able to induce the expression of Wnt-5a
directly (Blumenthal et al., 2006). In contrast, WNT5A
expression in lesional skin does not decrease during anti-
TNF-a treatment (unpublished observation), suggesting, that
in psoriasis lesions, Wnt-5a is not acting downstream of
TNF-a. Wnt-5a has also been shown to be induced through
stimulation of Toll-like receptor signaling, in which case,
neutralizing antibodies against TNF-a did not have any
suppressive effect (Blumenthal et al., 2006) indicating that
WNT5A expression can also occur independently of TNF-a,
which is consistent with the findings presented in our study.
Interestingly, neutralization of Wnt-5a led to a decrease in the
production of the cytokines IFN-g and IL-12p40 (the common
subunit of IL-12 and IL-23) (Blumenthal et al., 2006). IFN-g
and IL-23 have been shown to be crucial in the pathogenesis
of psoriasis through the maintenance and effector functions of
Th1 and Th17 cells (Uyemura et al., 1993; Cargill et al.,
2007; Krueger et al., 2007; Zaba et al., 2007). Recently, it
was reported that Wnt-5a may synergize with type 1 IFNs
such as IFN-a and IFN-b (Romanowska et al., 2009), and
type I IFNs have been implicated in the onset of psoriasis
(Nestle et al., 2005). These data support the notion that
Wnt-5a has a role in amplifying and/or maintaining the
inflammatory processes present in lesional skin.
Interestingly, IL-1a, TNF-a and IFN-g, and TGF-a, (a
member of the epidermal growth factor ligand family) were
able to induce expression of WNT5A by keratinocytes.
Although we were not able to detect any activity on
keratinocytes with recombinant Wnt-5a or Wnt-3a in vitro
as determined by both growth assays and migration assays
(data not shown), we observed growth-suppressive effect of
secreted Wnt-5a on human keratinocytes in vitro (Figure 6). It
should be noted that in vivo several of the Wnt proteins
including Wnt-1, Wnt-3a, and Wnt-5a have significant
posttranslational modifications (Kurayoshi et al., 2007) that
the commercially available recombinant proteins lack. The
Wnts are heavily glycosylated, which is essential for folding
and secretion (Kurayoshi et al., 2007) and several, including
Wnt-3a and Wnt-5a, are additionally conjugated to palmitate.
This palmitate conjugation is essential for their biological
activity and the lipid-unmodified form of Wnt-5a has been
shown to be unable to bind to Fz5 and therefore unable to
activate intracellular signal cascades and stimulate cell migra-
tion (Kurayoshi et al., 2007). This might be one of the reasons
for the observed lack of biological activity in vitro with either
recombinant Wnt-3a or Wnt-5a. Taken together, our study data
indicate that Wnt-5a may have a growth-suppressive effect on
the psoriatic epidermis, a finding that has been observed in
other settings (Olson et al., 1998), and may therefore be a part
of a regulatory mechanism keeping proliferation under control.
In conclusion, our study data indicate that there is a shift in
lesional psoriatic skin away from canonical Wnt signaling
toward noncanonical pathways likely mediated by the
increased expression and production of Wnt-5a and its
cognate receptors along with impaired homeostatic inhibition
of Wnt signaling by WIF-1 and the Dkk proteins. Our study
results and previously published studies indicate that Wnt-5a
may have a role in inducing the marked vascular changes in
lesional skin, influencing epidermal proliferation, and have a
role in the amplification of inflammatory responses. Further
studies are warranted to elucidate the exact role of the Wnt
pathway in psoriasis pathogenesis.
MATERIALS AND METHODS
Study Subjects
In all, 58 psoriatic cases and 64 normal healthy controls were
enrolled for the study. The criteria for entry as case were the
manifestation of one or more well-demarcated, erythematous, scaly
psoriatic plaques that were not limited to the scalp. In instances of
only a single psoriatic plaque, a plaque size of at least 1% of total
body surface area was required. Study subjects did not use any
systemic antipsoriatic treatments for 2 weeks before biopsy.
Informed consent was obtained from all subjects, under protocols
approved by the institutional review board of the University of
Michigan. This study was conducted in compliance with good
clinical practice and according to the Declaration of Helsinki
Principles. Local anesthesia was obtained with lidocaine HCl 1%
with epinephrine 1:100,000 (Hospira, Lake Forest, IL). Two biopsies
were taken from each patient; one 6mm punch biopsy was obtained
from lesional skin of patients and the other from uninvolved skin,
taken at least 10 cm away from any active plaque. One to two
biopsies were obtained from healthy controls. Immediately upon
removal, biopsies were snap-frozen in liquid nitrogen and stored
at 80 1C.
Microarrays
The biopsy samples were prepared as previously prescribed
(Gudjonsson et al., 2009b). Data from the most up- or down-
regulated probes were used for analysis.
Quantitation of mRNA Levels
Quantitative reverse transcription-PCR was performed on paired
lesional and nonlesional samples from 10 psoriatic patients and 10
normal controls. The RNA used was from the same samples used for
the gene microarrays. The reverse-transcription reaction was
performed on 0.5 mg of RNA template and cDNA was synthesized
using anchored-oligo(dT)18 primers as instructed by the manufac-
turer (Roche Diagnostics, Mannheim, Germany). QRT-PCR was
carried out using a LightCycler 2.0 system (Roche Diagnostics). The
reaction profile consisted of an initial denaturation at 95 1C for
15minutes followed by 40 cycles of PCR at 95 1C for 10 seconds
(denaturation), 58 1C for 10 seconds (annealing) and 72 1C for
10 seconds (extension). The fluorescence emitted was captured at
the end of the extension step of each cycle at 530 nm. Primers for the
genesWIF1,WNT5A,WNT3A, FZD1, FZD10, DKK2, KRT16, LRP6,
RAB5A, RAB27A, GNA15, and CCND1 were obtained from
Superarray Biosciences (Frederick, MD). Results were normalized
to the expression of the housekeeping gene ribosomal protein, large,
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P0 (RPLP0/36B4) (Laborda, 1991). QRT-PCR of cultured NHK was
carried out using cDNA prepared as above and primer sets for
DEFB4, CXCL1, WNT5A, and WIF1 were obtained from Applied
Biosystems and run on an Applied Biosystems 7900HT Fast Real-
Time PCR System with results normalized to RPLP0 expression.
Immunohistochemistry
Immunohistochemistry was performed on 5 mm fresh-frozen tissue
sections from uninvolved, lesional psoriatic, and control skin using
goat anti-Wnt5a (1 mgml1; Santa Cruz Biotechnology, Santa Cruz,
CA), mouse anti-WIF-1 (5mgml1; R&D Systems, Minneapolis, MN),
and goat anti-Fzd5 (2mgml1; R&D Systems) antibodies overnight at
4 1C, followed by the appropriate biotinylated secondary antibodies
(Vector Laboratories, Burlingame, CA), streptavidin-horseradish-
peroxidase conjugate (Vector Laboratories) and visualized with 3-
amino-9-ethyl-carbazole (BioGenex, San Ramon, CA), followed by
hematoxylin counterstaining (Biocare Medical, Concord, CA).
Stained sections were examined by light microscopy, and each
stained tissue section was subjected to image capture in its entirety
through five digital images taken with a  20 objective. All images
were subsequently analyzed using Image-Pro software (Image-Pro
Plus; Media Cybernetics, Silver Spring, MD), to quantify the area
stained in epidermis versus dermis (calculated as density per area).
Paraffin-embedded slides from normal controls (n¼ 3), unin-
volved psoriatic (n¼ 3), and lesional psoriatic (n¼ 3) were used for
b-catenin immunofluorescence staining. Antigen retrieval was
performed for 20minutes (Trizma base/EDTA) and the slides were then
incubated with mouse antihuman b-catenin (Sigma, St Louis, MO)
overnight at 4 1C. The slides were then washed three times and
incubated with secondary antibody (AF594 chicken anti-mouse;
Invitrogen, Carlsbad, CA). For Wnt5a CD31/CD34 counterstaining,
paraffin-embedded slides were processed as described above and
stained with goat anti-mouse Wnt5a (1:200 dilution; R&D Systems)
overnight followed by incubation with biotinylated anti-goat antibodies
for 30minutes and avidin-488 (1:200 dilution; Vector Laboratories) for
10minutes. The slides were then washed and counterstained with
either mouse anti-human CD34 (ready for use; Dako North America,
Carpinteria, CA) for 1hour, or CD31 (dilution 1:20; Dako North
America) for 1hour, followed by AF594 chicken-anti-mouse antibodies
(dilution 1:300; Invitrogen) for 30minutes. The slides were washed
three times and mounted with Vectashield fluorescent medium
containing 46-diamidino-2-phenyl indole (Vector Laboratories).
Keratinocyte Cultures
Normal human keratinocytes were obtained from sun-protected
adult skin by trypsin flotation and propagated in modified MCDB
153 medium (M154; Cascade Biologics, Portland, OR) as described
previously (Stoll et al., 2001), with the calcium concentration set at
0.1mM. To determine the proliferative effects of exogenous Wnt-5a
and WIF-1, we seeded NHK at a density of 2,000 cells per cm2 on
Costar 12-well polystyrene plates (Corning Life Sciences, Lowell,
MA) and allowed to attach for 48 hours. Cells were treated with
M154, Wnt-5a-conditioned medium (from L Wnt-5A cell line), or
medium conditioned by the parental untransfected cell line (L-M
(TK-1) line). The L-M(TK-1) (CCL-1.3) and L Wnt-5A cell lines (CRL-
2814) were obtained from ATCC (Manassas, VA).
To condition medium for use in experiments with NHK, we grew
the L Wnt-5a cell line as recommended, then passaged 1:10 and
grew in M154 without selection agents for 3 days. After 3 days
culture medium was collected and stored at 4 1C whereas a second
batch of conditioned medium was obtained from the same cells. On
day 6, cells were discarded and the two batches of media were
combined and stored at 20 1C until required,
Before use, conditioned media were diluted 1:4 in fresh M154 and
subsequently added to the NHK cultures, in the presence or absence
of recombinant human WIF-1 (300ngml1; R&D Systems) or Wnt-5a-
antibody (5mgml1; R&D Systems) for variable time periods (24–96h).
Cells were trypsinized and counted with a hemacytometer at the times
indicated. All experiments were performed in triplicates. Evaluation of
growth was also measured by flow cytometry after 96hours using
carboxyfluorescein diacetate succinimidyl ester-labeled NHK (Cell-
Trace CFSE Detection kit; Invitrogen). NHK were in a similar manner
exposed to recombinant Wnt-3a (200ngml1) and recombinant Wnt-
5a (200ngml1; R&D Systems) for variable time periods (24–96hours)
and were manually counted.
To examine the induction of Wnt proteins by proinflam-
matory cytokines, we grew NHK cultures to 40% confluency
or maintained to 4 days after confluence. Cultures were then starved
of growth factors in unsupplemented M154 for 24 hours before
use. Cultures were stimulated with recombinant human
TNF-a (10 ngml1), IL-17A (20 ngml1), IFN-g (20 ngml1), IL-22
(20 ngml1), IL-1a (10 ngml1) (R&D Systems) or TGF-a (24 ngml1;
R&D Systems) for 24 hours and processed for RNA isolation as
described above.
Western Blots
One 6-mm punch biopsy was obtained from normal skin from
healthy individuals (n¼ 3) and paired lesional and nonlesional
biopsies were obtained from psoriatic patients (n¼ 3) as described
above. Biopsies were snap-frozen in liquid nitrogen and stored
at 80 1C. Protein lysates were obtained by pulverizing the biopsies
while still frozen and the pulverized tissue was transferred to a 2ml
glass tissue grinder with 500ml of RIPA lysis buffer. The samples
were centrifuged at 4,500 r.p.m. for 4min and supernatants
collected. Protein concentrations were measured and all samples
were diluted to 1mgml1. Samples were separated on 10% SDS-
polyacrylamide gels and transferred to Immobilon-P membranes
(Millipore, Billerica, MA). Western blots were blocked with Tris-
buffered saline (TBS)/0.1% Tween 20 (TBS-T) containing 5% non-fat
dry milk for 1 hour at room temperature and incubated with Wnt-5a
antibody (dilution 1:1,000; Cell Signaling Technology, Danvers, MA)
overnight at 4 1C. The blots were washed three times with TBS-T and
then incubated with horseradish-peroxidase-conjugated rabbit sec-
ondary antibody (dilution 1:2,500; GE) for 1.5 hours at room
temperature. Blots were washed again and detected by chemilumi-
nescence using ECL (GE Healthcare, Piscataway, NJ) and Kodak
X-Omat film (Kodak, Rochester, NY). Anti-b-actin (dilution 1:2,500;
Sigma) was used as a loading control.
Statistical Analyses
Student’s t-test was used to analyze differences. A paired t-test was
used when uninvolved and lesional psoriatic data sets were
compared, unpaired t-test was used for other comparisons.
Quantitative immunohistochemistry data were tested for significance
using Student’s t-test assuming equal variances and P-values¼ 0.05
were considered statistically significant.
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Ingenuity Pathway Analyses
Microarray data were analyzed using Ingenuity Pathway Analysis
software (Ingenuity Systems, www.ingenuity.com). For network
generation, a data set containing gene identifiers and corresponding
expression values for WNT pathway genes was uploaded into the
application. Each gene identifier was mapped to its corresponding
gene object in the Ingenuity Pathways Knowledge Base. These
genes, called focus genes, were overlaid onto a global molecular
network developed from information contained in the Ingenuity
Pathways Knowledge Base.
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